CLX-1100

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameCLX-1100

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionTumor necrosis factor inhibitorsInterleukin-1 beta inhibitors

TargetsTumor necrosis factorInterleukin-1 beta

Therapy Area/IndicationsArthritis, Rheumatoid

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCalyxt Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesCalyxt Inc

Active IndicationsN/A

Inactive IndicationsArthritis, Rheumatoid

ATC CodeN/A